New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes?

Petermann Rocha, F., Chen, M., Gray, S. R. , Ho, F. K., Pell, J. P. and Celis Morales, C. (2020) New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Age and Ageing, 49(2), pp. 300-304. (doi: 10.1093/ageing/afz126)

[img] Text
194103.pdf - Accepted Version
Restricted to Repository staff only until 15 November 2020.

294kB

Abstract

Introduction: recently, the European Working Group on Sarcopenia in Older People (EWGSOP) established a new operational definition and cut-off points for sarcopenia. The aim of this study was, therefore, to compare the prevalence of sarcopenia and its associations with different health outcomes using the old (EWGSOP1) and new (EWGSOP2) definitions of sarcopenia in the UK Biobank cohort. Methods: sarcopenia was defined as low grip strength plus low muscle mass. Using both EWGSOP cut-off points, we created specific sarcopenia variables. Prevalence of sarcopenia derived using both EWGSOP definitions was calculated and compared as well as prospective health outcomes including all-cause mortality as well as incidence and mortality from cardiovascular disease (CVD), respiratory disease and chronic obstructive pulmonary disease (COPD). Results: the prevalence of sarcopenia based on the EWGSOP1 and EWGSOP2 classifications were 8.14 and 0.36%, respectively. Sarcopenia defined by EWGSOP1 was associated with a higher risk of respiratory disease and COPD as well as mortality from all-cause, CVD and respiratory diseases. However, only respiratory incidence remained associated with sarcopenia when EWGSOP2 was used (HR: 1.32 [95% CI: 1.05–1.66]). Moreover, although individuals classified as sarcopenic using both classifications had the highest risk of all-cause mortality and respiratory disease, those with sarcopenia based on EWGSOP1 only experienced a more extensive range of poorer health outcomes. Conclusion: in comparison with EWGSOP1, the new classification (EWGSOP2) produced a lower estimate of sarcopenia prevalence and fewer associations with adverse health outcomes. Although these associations were higher, many become non-significant.

Item Type:Articles
Additional Information:FP-R receives financial support from the Chilean Government for doing her Ph.D. (CONICYT-Becas Chile).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Celis, Dr Carlos and Pell, Professor Jill and Gray, Dr Stuart and Ho, Dr Frederick and Petermann, Mrs Fanny
Authors: Petermann Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., and Celis Morales, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > General Practice and Primary Care
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Public Health
Journal Name:Age and Ageing
Publisher:Oxford University Press
ISSN:0002-0729
ISSN (Online):1468-2834
Published Online:15 November 2019
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in 49(2):300-304
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record